SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudeep Pharma informs about certificate

10 Apr 2026 Evaluate
Sudeep Pharma has informed that it enclosed certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Company’s Registrar and Share Transfer Agent, MUFG Intime India for the quarter ended on 31st March 2026.

The above information is a part of company’s filings submitted to BSE.  

Sudeep Pharma Share Price

610.30 -3.45 (-0.56%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..
Register Now to get our Free Newsletter & much more!

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×